It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...

Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...

New tools tailored for use in senior living communities allow for shared experiences and social bonding. Credit...Morgan Lieberman for The New York Times Supported by By Charley Locke On a sunny ...

At present roughly one in five Americans reports taking or having taken a GLP-1, according to a recent poll. As the number of people using these medications has soared, so have anecdotal reports about ...

Four new tax deductions are available on federal returns for eligible taxpayers whether they itemize deductions, such as claiming mortgage interest, or claim the standard deduction. All four big tax ...

The Dabao Evaluation board is a tiny new single-board computer with a USB 2.0 Type-C port, a 20-pin GPIO header, and a custom RISC-V chip called the Baochip-1x. It’s that last bit that makes this ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Vintage illustration of a wealthy couple enjoying drinks at the high society club of the ...

When we design a microcontroller (MCU) project, we normally leave a few port lines unused, so that last-minute requirements can be met. Invariably, even those lines also get utilized as the project ...

While you can still get your hit of classic Counter-Strike on Steam, the original CS experience is getting an unofficial remake. Or rather, it was. Last year, it was revealed that a team of seasoned ...

The icon, who has cowritten a new book on obesity, tells PEOPLE she 'tried to beat the medication' Jamie Green In 2023, Oprah Winfrey revealed that she was taking GLP-1 weight loss medication, telling ...

CLEVELAND, Ohio — One in eight adults in the United States are now using Ozempic, Wegovy or similar GLP-1 drugs, according to a new KFF Health Tracking Poll. The poll also found that cost and side ...